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Antibacterial activityAbstract Biologically active Mannich bases with heteroaromatic ring system of substituted guan-
ine derivative (2-amino-9 [{(1,3 di hydroxy propane-2yl) oxy} methyl] 6-9 dihydro-3H-purine-6-
one) (ganciclovir), have been synthesized via Mannich reaction. The aminomethylation of
ganciclovir with various biologically potent sulphonamides was carried out and then characterized
by elemental analysis and spectral studies – UV, IR, 1H NMR, powder X-ray diffraction and
Scanning Electron Microscopy. The compounds were screened for their antibacterial activity
against various pathogenic bacteria at varying concentrations. The antibacterial activity of derived
Mannich bases was compared with parent sulphonamides. The toxicity of synthesized Mannich
bases was ascertained by LD50 test.
ª 2013 King Saud University. Production and hosting by Elsevier B.V. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
The chemistry of the aminoalkylation of aromatic substrates by
the Mannich reaction is of great interest for the synthesis and
modiﬁcation of biologically active compound having physical
(Tramontini and Angiolini, 1990) and chemical importance(Tramontini et al., 1998) as well as physiological properties (Sri-
ram et al., 2006;Mandloi et al., 2005; Ali and Shaharynar, 2007)
because the amino group can be easily converted into a variety
of other functionalities (Tramontini and Angiolini, 1994). Man-
nich reaction offers a judicious method for introduction of basic
aminoalkyl chain in various drugs/compounds. Further a con-
siderable amount of work has been reported on synthesis and
pharmacological activity of various Mannich bases for analge-
sic, antiinﬂammatory, anaesthetic and antimicrobial activity
as well as intermediates in drug synthesis (Blanton and Nobles,
1962; Jesudason et al., 2009). The heterocyclic system is reported
to have tremendous pharmaceutical importance (Katritzky,
2004). In this context, literature survey has revealed a number
of reports on antimicrobial activity of N-Mannich bases. 2-ami-
no-9[{(1,3 dihydroxy propane-2yl) oxy} methyl] 6-9 dihydro-3H-
purine-6-one, a guanine derivative is an antiviral drug, used in pre-
vention and treatment of cytomegalovirus (CMV) infection in
Synthesis, spectroscopic characterization and antibacterial screening of novel Mannich bases of Ganciclovir S1181HIV and transplant patients. It does not kill the virus but keeps
CMV infection under control (Sullivan et al., 1996). Ganciclovir
is indicated for prevention of CMV disease in bone marrow and
solid organ transplant recipients and it is also used for acute
CMV colitis in HIV/AIDS and CMV pneumonitis in immuno-
suppressed patients (Rossi, 2006). In addition to this the sulph-
onamide is well-known antibacterial (Joshi et al., 2003; Almajan
et al., 2009; Bayrak et al., 2009), antitubercular (Nishihara,
1953), anti-inﬂammatory (Li et al., 1995), carbonic inhibitory
(Supuran et al., 1998), insecticidal (Singh, 1970).
The Mannich bases incorporated with sulphonamides are
reported to be potent antibacterial agents and less toxic than
parent sulphonamide (Joshi et al., 2006). Keeping in view the
unique features of these compounds 2-amino-9[{(1,3 di hydro-
xy propane-2yl) oxy} methyl] 6-9 dihydro-3H-purine-6-one as
a substrate and sulphonamide as amine component were con-
densed via Mannich reaction. A series of Mannich bases were
synthesized with different sulphonamides/secondary amines
(Scheme 1). The synthesized Mannich bases were characterized
by elemental analysis and spectral studies-UV, IR, 1H NMR,
powder X-ray diffraction, SEM and screened for in vitro anti-
bacterial activity of gram-positive and gram-negative bacteria
at arbitrarily chosen concentrations.
2. Experimental
All the melting points were determined in open capillary
tubes and are uncorrected. Thin layer chromatography was
used for monitoring the reaction and to check purity. UV
spectra were studied on Schimadzu UV-160A, UV–visible
spectrophotometer; IR spectra (KBr) were recorded as
potassium bromide pellets on Schimadzu 820 IPC FTIR
spectrometer and 1H NMR spectra on Bruker DRX-300
FT NMR Spectrometer and chemical shifts were expressed
as (ppm) values against tetramethylsilane (TMS) as internal
reference. The XRD measurements were carried out on Bru-
ker D8 Advance X-ray diffractometer using CuKa at a
wavelength of 1.54 A˚. SEM studies were performed with a
Jeol JSM 5600 instrument having a magniﬁcation range of
·18 to ·300,000 and at an accelerating voltage of 0.5–
30 kV. The chemical reagents used in the synthesis were pur-
chased from E. Merck and Aldrich.
2.1. Chemistry
The reaction routes for the synthesis of the title compound
were described as shown in Scheme 1. The synthesized
Mannich bases (3a–3j) were obtained thus in (P85%) yield.2.1.1. Synthesis of Mannich bases (3a–3e)
In ethanolic solution of 0.01 mol of substrate (Comp.-1),
0.01 mol of sulphonamide and 2.5 mL of formaldehyde solu-
tion (37% v/v) were added. The pH of mixture was adjusted
to 3.5 by adding 0.5 ml of 1 mol1HCl. The mixture was
kept in an efﬁcient ice cooler for half an hour and then re-
ﬂuxed on a water bath. The reﬂux time is varied with the
sulphonamide used. Reﬂuxed mixture was kept at 0 C for
four days when crystalline product was obtained. The ob-
tained product was recrystallized with dry distilled ethanol
and DMF (1:1).2.1.2. Synthesis of Mannich bases (3f–3j)
Secondary amine 0.01 mol was added in an ethanolic solution
of 50 mL of substrate (Comp. -1) 0.01 mol in a ﬂat bottom
ﬂask. Amount of 0.4 mL of formaldehyde solution (37%)
was added slowly with constant stirring. The reaction mixture
was stirred at 70–75 C for 3.0–8.5 h, depending upon the sec-
ondary amine. The remaining portion of formaldehyde solu-
tion was added in two instalments after 1 and 2 h,
respectively. The reaction mixture was kept overnight in the
refrigerator. Next day, the excess of solvent was distilled off
from the reaction mixture under reduced pressure. It was again
kept for crystallization in the refrigerator. The product ob-
tained was puriﬁed by recrystallization from dry distilled eth-
anol and DMF (1:1).
2.2. Spectral Studies
Compound 3a: C20H23N9O6S; yield 80%, m.p. 160–163 C.
Anal. Calcd C, 46.40; H, 4.58; N, 24.36 Found C, 46.16; H,
4.42; N, 24.23. UV (k max) nm: 208 (C‚O), 190 (C‚N),
205 (sulphonamide group), 186, 207, 251 (for benzene chromo-
phore), 254 (sulphonamide moiety). IR (KBr) v max in cm1:
3442 ts N–H, 3398 tas N–H in SO2NH, 3302 ts O–H, 2940 tas
CH2, 1688 ts C‚O, 1345 ts S‚O, 1130 C–H in plane bending
vibration of 1:4 disubstituted benzene. 1H NMR (DMSO)
d ppm: 5.04 (s, 2H, CH2), 5.5 (s, 2H, CH2 attached to purine
ring), 6.36 (S, 1H of sulphonamide), 7.93 (s, 1H, CH of purine
ring), 7.84 (s, 1H, free OH of Comp. 1), 9.03 (s, 1H of
SO2NH), 6.6–7.2 (m, ring proton of sulphonamide), 7.48–
8.47 (m, 3H of sulphadiazine ring).
Compound 3b: C20H22N9O8S; yield 72%, m.p. 105–107 C.
Anal. Calcd. C, 45.74; H, 4.71; N, 21.82; Found C, 45.61; H,
4.46; N, 21.64. UV (k max) nm: 210 (C‚O), 197 (C‚N),
208 S‚O, 182, 205, 250 for benzene chromophore; 258 sulph-
onamide moiety. IR (KBr) v max in cm1: 3440 ts N–H, 3380
tas N–H in SO2NH, 3302 ts O–H, 2910 tas C–H in CH2, 1653
ts C‚O, 1380 ts S‚O, 1135 C–H in plane bending vibration
of 1:4 disubstituted benzene; 1H NMR (DMSO) d ppm: 3.43
(s, 3H of OCH3) 5.04 (s, 2H, CH2), 5.5 (s, 2H, CH2 attached
to purine ring), 6.4 (s, 1H of sulphonamide), 7.9 (s, 1H, CH
of purine ring), 7.4 (s, 1H, free OH of Comp. 1), 9.2 (s, 1H
of SO2NH), 6.6–7.07 (m, ring proton of sulphonamide).
Compound 3c: C20H24N8O7S; yield 84%, m.p. 180–181 C,
Anal. Calcd. C, 46.13; H, 4.65; N, 21.53; Found C, 46.13; H,
4.25; N, 21.33. UV (k max) nm: 201 (C‚O), 192 (C‚N),
208 (S‚O), 186, 207, 250 for benzene chromophore; 255 (sul-
phonamide moiety). IR (KBr) v max in cm1: 3475 ts N–H,
3350 tas N–H in SO2NH, 3318 ts O–H, 2915 tas C–H in
CH2, 1685 ts C‚O, 1349 ts S‚O, 1110 C–H in plane bending
vibration of 1:4 disubstituted benzene. 1H NMR (DMSO)
d ppm: 2.71(s, 3H of CH3) 5.04 (s, 2H, CH2), 5.5 (s, 2H,
CH2 attached to purine ring), 6.3 (s, 1H of sulphonamide).
Compound 3d: C18H22N7O7NaS; yield 78%, m.p. 90 C,
Anal. Calcd. C, 42.93; H, 4.41; N, 19.48 Found C, 42.52; H,
4.21; N, 19.22. UV (k max) nm: 208 (C‚O), 190 (C‚N),
205 S‚O, 186, 207, 251 for benzene chromophore; 254 sulph-
onamide moiety. IR (KBr) v max in cm1: 3482 ts N–H, 3351
tas N–H in SO2NH, 3295 ts O–H, 2950 tas C–H in CH2, 1647
ts C‚O, 1385 ts S‚O, 1109 C–H in plane bending vibration
of 1:4 disubstituted benzene. 1H NMR (DMSO) d ppm: 2.16
(s, 3H acetamide CH3) 5.04 (s, 2H, CH2), 5.5 (s, 2H, CH2
Scheme 1 Synthesis of Mannich bases from primary amines and secondary amines.
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(s, 1H, CH of purine ring), 6.7 (s, 1H, OH of Comp. 1), 9.42 (s,
1H of SO2NH), 6.6–7.07 (m, ring proton of sulphonamide).
Compound 3e: C20H22N9O6SAg; yield 85%, m.p. 222 C.
Anal. Calcd. C, 38.46; H, 3.55; N, 20.19 Found C, 38.32; H,
3.51; N, 20.24. UV (k max) nm: 203 (C‚O), 194 (C‚N),
208 S‚O, 180, 203, 250 for benzene chromophore; 257 sulph-
onamide moiety. IR (KBr) v max in cm1: 3496 ts N–H, 3348
tas N–H in SO2NH, 3300 ts O–H, 2952 tas C–H in CH2, 1638
ts C‚O, 1355 ts S‚O, 1100 C–H in plane bending vibrationof 1:4 disubstituted benzene. 1H NMR (DMSO) d ppm: 5.04
(s, 2H, CH2), 5.5 (s, 2H, CH2 attached to purine ring), 6.1
(s, 1H, NH of sulphonamide), 7.9 (s, 1H, CH of purine ring),
6.72 (s, 1H, OH of Comp. 1), 6.6–7.2 (m, ring proton of
sulphonamide).
Compound 3f: C14H24N6O6; yield 80%, m.p. 160–162 C.
Anal. Calcd. C, 45.14; H, 6.49; N, 22.56 Found C, 45.13; H,
6.51; N, 22.50. UV (k max) nm: 208 (C‚O), 191 (C‚N),
185 205, 250 for benzene chromophore. IR (KBr) v max in
cm1: 3482 ts N–H, 3352 ts O–H, 2944 tas C–H in CH2,
Figure 2 Powder X-ray diffraction pattern of ganciclovir methyl
diphenylamine.
Figure 3 Powder X-ray diffraction pattern of ganciclovir methyl
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1H NMR (DMSO) d ppm: 4.51 (s, 2H,CH2),
5.60 (s, 2H, CH2 attached to purine ring), 7.9 (s, 1H, CH of
purine ring), 4.92 (s, 1H, OH of Comp. 1).
Compound 3g: C12H20N6O4; yield 71%, m.p. 225–227 C,
Anal. Calcd. C, 46.13; H, 6.46; N, 26.90 Found C, 46.4; H,
6.51; N, 26.82. UV (k max) nm: 210 (C‚O), 195 (C‚N),
185, 205, and 255 for benzene chromophore. IR (KBr) v max
in cm1: 3412 ts N–H, 3310 ts O–H, 2909 tas C–H in CH2,
1655 ts C‚O.
1H NMR (DMSO) d ppm: 4.48 (s, 2H, CH2),
5.5 (s, 2H, CH2 attached to purine ring), 7.9 (s, 1H, CH of pur-
ine ring), 6.12 (s, 1H, OH of Comp. 1).
Compound 3h: C14H22N6O5; yield 79%, m.p. 215–218 C,
Anal. Calcd. C, 47.43; H, 6.26; N, 23.71 Found C, 47.32; H,
6.30; N, 23.52. UV (k max) nm: 204 (C‚O), 190 (C‚N),
184, 209, and 254 for benzene chromophore. IR (KBr) v max
in cm1: 3477 ts N–H, 3361 ts O–H, 2947 tas C–H in CH2,
1630 ts C‚O, 1244 ts C–O.
1H NMR (DMSO) d ppm: 4.4
(s, 2H, CH2), 5.5 (s, 2H, CH2 attached to purin ring), 7.93
(s, 1H, NH of purine ring), 6.21 (s, 1H, OH of Comp. 1).
Compound 3i: C22H24N6O4; yield 82%, m.p. 235–236 C,
Anal. Calcd. C, 60.52; H, 5.55; N, 19.25 Found C, 60.61; H,
5.32; N, 19.10. UV (k max) nm: 209 (C‚O), 190 (C‚N),
184, 206, and 260 for benzene chromophore. IR (KBr) v max
in cm1: 3406 ts N–H, 3318 ts O–H, 2932 tas C–H in CH2,
1643 ts C‚O.
1H NMR (DMSO) d ppm: 4.5 (s, 2H, CH2),
5.5 (s, 2H, CH2 attached to purine ring), 7.9 (s, 1H, CH of pur-
ine ring), 6.17 (s, 1H, OH of Comp. 1).
Compound 3j: C14H23N7O4; yield 80%, m.p. 220 C. Anal.
Calcd C, 47.57; H, 6.56; N, 27.74 Found C, 47.80; H, 6.32;
N, 27.62. UV (k max) nm: 205 (C‚O), 190 (C‚N), 184,
206, and 260 for benzene chromophore. IR (KBr) v max in
cm1: 3458 ts N–H, 3342 ts O–H, 2937 tas C–H in CH2,
1639 ts C‚O.
1H NMR (DMSO) d ppm: 4.5 (s, 2H, CH2),
5.5 (s, 2H, CH2 attached to purine ring), 7.9 (s, 1H, CH of pur-
ine ring), 5.5 (s, 1H, OH of Comp. 1).
2.2.1. Powder X-ray diffraction studies
Powder X-ray diffraction patterns of three of the synthesized
compounds namely ganciclovir methyl silver sulphadiazine
(3e), ganciclovir methyl diphenylamine (3i) and ganciclovir
methyl Piperazine (3j) (Figs. 1–3, respectively) have beenFigure 1 Powder X-ray diffraction pattern of ganciclovir methyl
silver sulphadiazine.
piperazine.reported and important structural information has been shown
in Tables 1–3, respectively.
Average particle size of the synthesized compound was
determined with the help of the Scherrer formula, in which
particle size D is deﬁned as 0.9k/B cosh,
Where 0.9 = constant, k = wavelength, B = angular
width and h= diffraction angle average particle size of the
compounds determined was 94.18, 32.03 and 64.13 nm respec-
tively. Diffraction data of the compounds are listed in Tables
1–3. All of our synthesized compounds had an orthorhombic
crystal system and XRD patterns showed that all are polycrys-
talline in nature. The largest relative deviation between the cal-
culated and experimental d value was nearly equal to one,
which indicates that all the synthesized compounds are multi-
phase compounds. Interplaner d spacing and unit cell volume
of the synthesized compound were calculated by the formulae:
Table 1 The experimental data and the calculated results for
powder X-ray pattern of the ganciclovir methyl silver
sulphadiazine.
2h d Spacing (A˚)
observed
d Spacing (A˚)
calculated
Relative
intensity (%)
hkl
19.79 4.48 4.46 98.96 210
20.58 4.31 4.14 73.17 023
22.37 3.96 4.00 43.61 220
24.19 3.67 3.67 84.83 004
25.53 3.48 3.48 37.33 141
26.59 3.34 3.04 50.69 043
27.79 3.20 3.32 100 133
29.17 3.05 3.31 19.97 114
30.81 2.89 2.73 22.32 152
31.98 2.79 2.85 46.99 134
33.09 2.70 2.46 55.81 134
34.50 2.59 2.59 25.63 060
35.94 2.49 2.40 27.90 045
37.08 2.42 2.42 32.71 340
38.43 2.33 2.33 42.30 400
39.45 2.28 2.26 15.31 260
40.89 2.20 2.36 29.36 106
43.17 2.09 2.46 24.98 161
45.99 1.97 1.98 31.87 360
47.78 1.90 2.20 19.51 421
48.89 1.86 2.13 15.74 171
49.21 1.84 1.81 17.32 520
Lattice parameters and angle calculated are: a= 9.32 A˚ or
0.93 nm, b= 15.54 A˚ or 1.55 nm, C= 14.68 A˚ or 1.46 nm,
b= 94.18. Unit cell volume of the complex: 2,126.14 · 108 cm.
Table 2 The experimental data and the calculated results for
powder X-ray pattern of the ganciclovir methyl biphenyl
amine.
2h d spacing (A˚)
Observed
d spacing (A˚)
Calculated
Relative
intensity (%)
h k l
10.97 8.05 8.00 27.38 110
14.87 5.94 5.94 10.07 120
20.76 4.27 4.24 22.82 102
21.99 4.03 4.00 31.25 220
23.75 3.74 4.20 100 201
24.74 3.59 3.56 15.36 140
27.97 3.18 3.18 10.12 003
29.05 3.06 3.34 10.54 202
30.46 2.14 3.01 8.14 103
32.30 2.76 3.28 17.48 212
36.46 2.46 2.61 7.52 302
37.61 2.38 2.96 7.94 301
38.40 2.34 2.34 7.63 400
40.04 2.24 2.25 7.28 260
44.00 2.05 2.40 7.03 161
45.02 2.01 1.98 6.48 360
46.81 1.93 1.93 7.01 080
47.04 1.92 2.18 6.98 421
48.54 1.87 2.10 7.49 171
49.15 1.85 1.81 6.18 520
Lattice parameters and angle calculated are: a= 9.36 A˚ or
0.93 nm, b= 15.44 A˚ or 1.54 nm, C= 9.54 A˚ or 0.954 nm,
b= 32.03. Unit cell volume of the complex: 1,378.70 · 108 cm.
Table 3 The experimental data and the calculated results for
powder X-ray pattern of the ganciclovir methyl piperazine.
2h d spacing(A˚)
Observed
d spacing(A˚)
Calculated
Relative
intensity (%)
h k l
19.85 4.53 4.53 10.43 200
22.25 4.06 4.12 46.49 113
23.78 3.81 3.81 100 040
25.71 3.54 3.51 21.29 140
27.97 3.28 3.38 6.57 042
28.67 3.20 3.27 55.90 133
30.08 3.07 3.51 4.90 140
31.98 2.90 2.80 7.92 320
34.76 2.70 2.72 14.79 025
39.16 2.43 2.43 4.59 006
40.16 2.38 2.95 4.99 301
41.68 2.31 2.83 6.86 151
43.06 2.25 2.21 4.76 260
44.26 2.20 2.52 4.55 144
46.81 2.11 2.14 4.96 206
47.89 2.07 2.41 6.18 161
49.39 2.02 1.94 4.30 360
Lattice parameters and angle calculated are: a= 9.06 A˚ or
0.90 nm, b= 15.24 A˚ or 1.52 nm, C= 14.58 A˚ or 1.45 nm,
b= 64.13. Unit cell volume of the complex: 2,013.12 · 108 cm.
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Peaks having important characteristic information have been
identiﬁed with the help of standard diffraction card JCPDS
31–1859, 38–1709, 49–2499 and 35–1687 and indicate the for-
mation of nanosized, polycrystalline, two phase and low sym-
metry compounds.
2.2.2. Scanning Electron Microscopy (SEM) studies
Scanning Electron Microscopy studies of two of the synthe-
sized compounds namely ganciclovir methyl silver sulphadi-
azine (3e), and ganciclovir methyl piperazine (3j) have been
carried out at a magniﬁcation of ·1000  10 lm and
·600  2 lm. SEM uses a focused beam of high energy elec-
trons to generate a variety of signals from the surface of signals
revealing information about the sample, including external
morphology, topography, chemical composition crystalline
structure, and orientation of materials making up the sample.
We recorded different magniﬁcations, as described above.
Compound ganciclovir methyl silver sulphdiazine (3e) (Figs. 4
and 5) has a different topography and morphology at the two
different magniﬁcations. In the images, the particles exhibit
different sizes and shapes, and are present in the form of closed
polygonal structure hand, the compound ganciclovir methyl
piperazine (3j) (Figs. 6 and 7) shows at different magniﬁcations
a ﬁner morphology as compared to the other compound, ap-
pears in the form of simple polygonal structures.
SEM studies show microstructure of the compounds, which
mainly include surface morphology.
2.3. Antimicrobial activity and LD50 test
The newly synthesized Mannich bases 3a–3j were screened for
their antibacterial activity against pathogenic strains of
Escherichia coli, Staphylococcus aureus and Bacillus subtilis at
varying concentrations-80 lg/ml, 160 lg/ml and 320 lg/ml
Figure 4 SEM image of ganciclovir methyl silver sulphadiazine
(magniﬁcation of ·1,000  10 lm).
Figure 5 SEM image of ganciclovir methyl silver sulphadiazine
(magniﬁcation of ·600  2 lm).
Figure 6 SEM image ganciclovir methyl piperazine (magniﬁca-
tion of ·1000  10 lm).
Figure 7 SEM image ganciclovir methyl piperazine (magniﬁca-
tion of ·600  2 lm).
Synthesis, spectroscopic characterization and antibacterial screening of novel Mannich bases of Ganciclovir S1185using corresponding sulphonamides as their standards by the
cup plate method. Nutrient agar media were prepared for bac-
terial growth. The media were autoclaved at 15 lbs pressure(121.6 C) for 30 min. The culture of bacterium was mixed with
autoclaved media and poured in plates and bored. The solu-
tion of Mannich bases was poured in these cups in triplicate
and incubated at 37 C for 24 h. Antibacterial activity was
ascertained by the zone of inhibition measured in mm as
shown in Table 4. The similar procedure was followed for
the parent sulphonamides.
The toxicity of synthesized Mannich bases was ascertained
by LD50 test. The test performed on white mice weighing 25 g.
Doses were given orally as well as intraperitoneally and mice
were kept under observation for 72 h for each trial. The Man-
nich bases showed no adverse toxic effect even at an oral dose
of 1400 mg/kg of the body weight of mice. However when the
dose was administered intraperitoneally they proved be lethal
at the dose level of 800 mg/kg of the body weight of mice.
3. Results and discussion
The Mannich bases synthesized by Mannich reaction were ob-
tained in good yield (P85%). They were analysed for elemen-
tal analysis and results were found to be in full agreement with
the calculated values. The anticipated structure was in agree-
ment with the spectral data – UV, IR and 1H NMR. The pur-
ity of synthesized compounds was assured with the aid of the
chromatographic technique. The stationary phase was silica
gel-G. It was of chromatographic grade. The solvents used
for the mobile phase were methanol and chloroform. They
were distilled before use. The spectral studies have shown a
characteristic band due to the methylene group incorporated
between active hydrogen substrate and the amine component
as a result of Mannich reaction at (2940–2950) and (1442–
1450). This shows the presence of amino methyl linkage in
the synthesized Mannich bases. The 1H NMR also conﬁrms
aminomethyl linkage (–CH2) between amine and active hydro-
gen (5.04–5.20). Some of the synthesized compounds are of
nano size. The use of nano particle in medicine offers some
exciting possibilities. Some techniques are only imagined, while
others are at various stages of testing, or actually being used
today. The Mannich bases were screened for their biological
signiﬁcance. They were evaluated for antibacterial activity
against pathogenic strains of E. coli, S. aureus and B. subtilis
at varying concentrations – 80, 160 and 320 lg/ml. These
Table 4 Antibacterial screening of synthesized Mannich bases and sulphonamides against E. coli, S. aureus and B. subtilis (Zone of
inhibition in mm).
Comp. No. E.coli
Concentration in lg/ml
S.aureus
Concentration in lg/ml
B.subtilis
Concentration in lg/ml
80 160 320 Avg 80 160 320 Avg 80 160 320 Avg
3a 8.6 9.6 11.6 9.9 8.6 10.3 12.3 10.4 – – – –
3b 8.6 9.6 12.6 10.2 9.3 10.6 13.3 11.0 7.6 8.0 12.3 9.3
3c 7.6 8.3 11.6 9.1 7.3 8.0 11.0 8.7 8.3 10.0 12.6 10.3
3d 9.6 11.3 13.3 11.4 9.6 11.0 14.3 11.6 – 7.3 15.6 7.6
3e 13.3 14.0 17.6 15.1 7.3 10.6 12.3 10.1 8.6 10.6 11.6 10.2
3f – – 11.6 3.8 – – 7.3 2.4 – – – –
3g – – 9.0 3.0 – – 8.3 2.7 7.3 8.3 10.0 8.5
3h – – 14.6 4.8 – 9.0 11.6 6.8 – – – –
3i – – 10.3 4.8 – 8.0 11.6 6.8 7.3 8.3 10.0 8.5
3j – – 15.3 5.1 – – 11.6 3.8 7.6 9.6 10.6 7.2
2a 12.0 16.6 20.0 16.0 15.6 18.6 21.3 18.5 17.0 19.6 27.6 21.4
2b 14.6 17.0 19.0 16.8 15.3 19.0 20.0 18.0 17.3 21.6 27.3 22.1
2c 14.0 16.3 20.0 16.7 10.6 16.0 19.3 15.3 15.6 18.0 19.6 17.7
2d 9.6 11.6 17.6 12.9 9.0 11.0 14.6 11.5 9.6 17.6 21.6 16.2
2e 9.6 10.3 16.0 11.7 7.3 8.3 11.0 8.8 8.6 10.3 12.6 10.5
*Avg: average value of antibacterial activity (for 80, 160 and 320 lg).
S1186 S. Joshi et al.pathogens were subcultured on speciﬁc media. The Mannich
bases and the standard compound (sulphonamide and second-
ary amines) were dissolved in DMF. The activities reported
were mean of zone of inhibition in millimetre (in triplicate).
All the reported compounds exhibit remarkable in vitro activ-
ity against these pathogens. Their activity was also compared
with their parent sulphonamides.
Table 4 reﬂects that most of the compounds had shown
remarkable activity only at 320 lg/ml. Derived Mannich bases
show activity against this pathogen but 3e was superior to oth-
ers followed by 3d and 3b in inhibiting the growth of E. coli. A
comparison with parent sulphonamides shows that Mannich
bases 3e were superior to the corresponding sulphonamides
and the other mannich bases are equally potent than the cor-
responding sulphonamides.
The Mannich bases 3b, 3d, 3e were signiﬁcantly superior to
other compounds in exhibiting antibacterial activity against S.
aureus. Comparative study with sulphonamides indicates that
Mannich base 3d and 3e are superior to the corresponding sul-
phacetamide sodium and silver sulphadiazine. Moreover, con-
centration of 320 lg/ml was superior for inhibiting the growth
of the bacterium.
Study against B. subtilis revealed that 3c was best among all
Mannich bases, which were moderately active, followed by 3e
and 3b, in checking the growth of the pathogen. Moreover,
concentration of 320 lg/ml was most effective for showing
antibacterial activity.
Comparisonwith sulphonamides shows that,Mannich bases
and sulphonamides show antibacterial activity, but the former is
less toxic than the latter as revealed byLD50 test onwhitemice of
weight 25 g. The newly synthesized compounds seem to be really
promising compounds for their antibacterial activity. In the
light of those ﬁndings wewill undertake further synthetic studies
on the new compounds in the future.
4. Conclusion
Conclusions suggest that the newly synthesized Mannich
bases of ganciclovir have a very noticeable and prolongedantibacterial activity. These derived Mannich bases are less
toxic in comparison with their parent sulphonamides. This
work shows that Mannich bases are a potential source of com-
pounds for inhibition of bacteria and could be used as efﬁcient
drugs with minimum side effects.Acknowledgements
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